Skip to Content

Hypera SA ADR HYPMY Stock Quote

| Rating as of


Last close prices updated as of Jun 02, 2023, 1:26 PM EST | USD
  • Last Close 7.90
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Large Growth
  • Day Range 8.43  –  8.49
  • Year Range 6.81  –  9.60
  • Market Cap 5.3652 Bil
  • Volume / Avg 5,077.0 /  5,229.6
  • Price / Sales 3.25
  • Price / Book 2.33
  • Forward Div Yield 2.92%
  • Trailing Div Yield 2.72%

Morningstar‘s Stock Analysis HYPMY

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics HYPMY

Company Profile HYPMY

Business Description

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim
Sao Paulo, SP, CEP 05676-120, BRA
Industry Drug Manufacturers - Specialty & Generic
Employees 9,000

Competitors & Peers HYPMY

Morningstar does not cover competitors or peers for this firm.

FAQs for Hypera SA ADR Stock

Yes. HYPMY has a forward dividend yield of 2.92%. See HYPMY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

HYPMY’s market cap is 5.37 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

HYPMY’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

HYPMY’s price/sales is 3.32.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

HYPMY’s price/forward earnings is 15.35.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

HYPMY’s price/book is 2.36.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See HYPMY’s valuation ratios compared to the Market Index.

HYPMY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare HYPMY’s historical performance against its industry peers and the overall market.